Low RAI2 expression is a marker of poor prognosis in breast cancer

被引：0
|
作者：
Sayaka Nishikawa
Yasuaki Uemoto
Tae-Sun Kim
Tomoka Hisada
Naoto Kondo
Yumi Wanifuchi-Endo
Takashi Fujita
Tomoko Asano
Yusuke Katagiri
Mitsuo Terada
Akiko Kato
Yu Dong
Hiroshi Sugiura
Katsuhiro Okuda
Hiroyuki Kato
Satoshi Osaga
Satoru Takahashi
Tatsuya Toyama
机构：
[1] Nagoya City University Graduate School of Medical Sciences,Department of Breast Surgery
[2] Nagoya City University Graduate School of Medical Sciences,Advanced Medicine
[3] Nagoya City University Graduate School of Medical Sciences,Department of Oncology, Immunology and Surgery
[4] Nagoya City University Graduate School of Medical Sciences,Department of Experimental Pathology and Tumor Biology
[5] Nagoya City University Hospital,Clinical Research Management Center
[6] Toyokawa City Hospital,Department of Breast and Endocrine Surgery
来源：
Breast Cancer Research and Treatment | 2021年 / 187卷
关键词：
Breast cancer; Retinoic acid-induced 2 (RAI2); Disseminated tumor cells (DTC);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：81 / 93
页数：12
相关论文
共 50 条
  • [1] Low RAI2 expression is a marker of poor prognosis in breast cancer
    Nishikawa, Sayaka
    Uemoto, Yasuaki
    Kim, Tae-Sun
    Hisada, Tomoka
    Kondo, Naoto
    Wanifuchi-Endo, Yumi
    Fujita, Takashi
    Asano, Tomoko
    Katagiri, Yusuke
    Terada, Mitsuo
    Kato, Akiko
    Dong, Yu
    Sugiura, Hiroshi
    Okuda, Katsuhiro
    Kato, Hiroyuki
    Osaga, Satoshi
    Takahashi, Satoru
    Toyama, Tatsuya
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (01) : 81 - 93
  • [2] Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer
    Jiao, Ying
    Li, Shiyu
    Gong, Juejun
    Zheng, Kun
    Xie, Ya
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Retinoic acid-induced 2 (RAI2) is a potential tumor suppressor and RAI2 promoter methylation is a poor prognostic marker in colorectal cancer
    Yan, W.
    Wu, K.
    Yang, Y.
    Guo, M.
    Dai, G.
    ANNALS OF ONCOLOGY, 2018, 29 : 53 - 53
  • [4] Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer
    Yan, Wenji
    Wu, Kongming
    Herman, James G.
    Xu, Xiuduan
    Yang, Yunsheng
    Dai, Guanghai
    Guo, Mingzhou
    CLINICAL EPIGENETICS, 2018, 10
  • [5] Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer
    Wenji Yan
    Kongming Wu
    James G. Herman
    Xiuduan Xu
    Yunsheng Yang
    Guanghai Dai
    Mingzhou Guo
    Clinical Epigenetics, 2018, 10
  • [6] Low TINAGL1 expression is a marker for poor prognosis in breast cancer
    Kato, Akiko
    Kondo, Naoto
    Wanifuchi-Endo, Yumi
    Fujita, Takashi
    Asano, Tomoko
    Hisada, Tomoka
    Uemoto, Yasuaki
    Terada, Mitsuo
    Kato, Hiroyuki
    Komura, Masayuki
    Okuda, Katsuhiro
    Takahashi, Satoru
    Toyama, Tatsuya
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 4771 - 4782
  • [7] Low TINAGL1 expression is a marker for poor prognosis in breast cancer
    Akiko Kato
    Naoto Kondo
    Yumi Wanifuchi-Endo
    Takashi Fujita
    Tomoko Asano
    Tomoka Hisada
    Yasuaki Uemoto
    Mitsuo Terada
    Hiroyuki Kato
    Masayuki Komura
    Katsuhiro Okuda
    Satoru Takahashi
    Tatsuya Toyama
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 4771 - 4782
  • [8] The prognostic impact of retinoic acid-induced 2 (RAI2) expression in ERα-positive breast cancer patients
    Nishikawa, Sayaka
    Kondo, Naoto
    Endo, Yumi
    Hato, Yukari
    Hisada, Tomoka
    Nishimoto, Mayumi
    Dong, Yu
    Okuda, Katsuhiro
    Kato, Hiroyuki
    Takahashi, Satoru
    Nakanishi, Ryoichi
    Toyama, Tatsuya
    CANCER RESEARCH, 2018, 78 (04)
  • [9] SKP2 IS A MARKER OF POOR PROGNOSIS IN BREAST CANCER
    Goulart, J.
    Nielsen, T.
    Voduc, D.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S43 - S43
  • [10] Novel function of the RAI2 protein in genomic integrity of breast cancer cells
    Werner, Stefan
    Borgmann, Kerstin
    Pantel, Klaus
    Wikman, Harriet
    CANCER RESEARCH, 2016, 76
12345